These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3463241)

  • 1. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562.
    Tsuruo T; Oh-Hara T; Saito H
    Anticancer Res; 1986; 6(4):637-41. PubMed ID: 3463241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
    Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
    Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T
    Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
    Naito M; Tsuruo T
    Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and properties of vincristine-resistant human myelogenous leukemia K562.
    Tsuruo T; Iida H; Ohkochi E; Tsukagoshi S; Sakurai Y
    Gan; 1983 Oct; 74(5):751-8. PubMed ID: 6580255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in effects of alkyl-lysophospholipids and verapamil on vincristine transport in vincristine-sensitive and -resistant human myelogenous leukemia K562.
    Tsuruo T; Saito H
    Anticancer Res; 1987; 7(1):39-43. PubMed ID: 3471174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP/Mg2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells.
    Naito M; Hamada H; Tsuruo T
    J Biol Chem; 1988 Aug; 263(24):11887-91. PubMed ID: 3165378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins.
    Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC
    Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
    Sone S; Ishii K; Tsuruo T
    Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 May; 43(5):2267-72. PubMed ID: 6831450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
    Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic approach against drug-resistant tumors and their biochemical nature].
    Tsuruo T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1636-41. PubMed ID: 3592707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of high expression of HSP27 to multidrug resistance of leukemia cell line K562/VCR].
    Zhang ZX; Wen FQ; Liu ZP; Cheng YD
    Ai Zheng; 2008 Apr; 27(4):348-53. PubMed ID: 18423118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
    Conter V; Beck WT
    Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.